BioSpace News Archive

Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Life Sciences Limited, announced today that the first patient enrolled in its Phase 1 clinical trial for the oral therapeutic GZ17-6.02 received the first dose this week at HonorHealth Research Institute in Scottsdale, Ariz

To raise money for childhood cancer research, more than 12 volunteers shaved their heads at a recent St. Baldrick’s Foundation event.

The American Osteopathic Association (AOA), the professional membership organization for the nation’s more than 145,000 osteopathic physicians (DOs) and medical students, is pleased to announce that its board of trustees has appointed Kevin Klauer, DO, EJD, FACEP, as chief executive officer.

axialHealthcare, a national leader in pain care and opioid medication solutions, announced today a series of leadership transitions designed to meet the growing company’s increased operational needs and to poise the organization for future growth and expansion.

Swiss American CDMO (Contract Development and Manufacturing Organization), a Dallas-based company that specializes in skin and wound care products, was recently named one of the top 10 Contract Manufacturers in the country by MedTech Outlook

The Leukemia & Lymphoma Society (LLS), the world’s largest nonprofit dedicated to fighting blood cancer, knows all too well the devastation cancer causes for families and communities.

Syngenta and the Analytics Society of INFORMS have announced the finalists for the 2019 Syngenta Crop Challenge in Analytics.

Merck KGaA, Darmstadt, Germany and Pfizer Inc. announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by maintenance therapy of avelumab in combination with talazoparib,* a poly polymerase inhibitor, versus an active comparator in treatment-naïve patients with locally advanced or metastatic ovarian cancer.

Chinese leading biotechnology company 3SBio (01530.HK) today released its 2018 annual results, showing that the Company has been posting dramatic business growth, and has been gearing up R&D layout and investment in innovative drugs.

Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.